Kidney Dysfunction: Clinical Trials

3 trials for Kidney Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 11Completed 1

Follow Kidney Dysfunction: new trials by email Literature Review of Kidney Dysfunction trials Research Report on Kidney Dysfunction

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor
Clopidogrel, Ticagrelor - Platelet Aggregation, Adenosine
Phase 2CompletedUniversity of Sao Paulo902017-11-072020-04-24
Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia
Zirconium silicate (ZS), Placebo - Hyperkalemia, Chronic Kidney Disease
Phase 2CompletedZS Pharma, Inc.902011-11-302018-06-29
The Effects of Decreasing the Lasix Dose on the Cardiorenal System
Furosemide - Heart Failure, Kidney Dysfunction
Phase 1 / Phase 2CompletedMayo Clinic412009-07-012015-07-20

Narrower conditions

Coronary Artery Disease (1)  ·  Heart Failure (1)  ·  Hyperkalemia (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Chronic Disease (1)  ·  Coronary Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Metabolic Diseases (1)  ·  Myocardial Ischemia (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)

Interventions

Clopidogrel (1)  ·  Furosemide (1)  ·  Ticagrelor (1)  ·  zircon (1)

Sponsors

Mayo Clinic (1)  ·  University of Sao Paulo (1)  ·  ZS Pharma, Inc. (1)

Countries

United States (2)  ·  Brazil (1)

Top investigators

Henrik Rasmussen, MD (1)  ·  Horng H Chen, MD (1)

Results publications

PMID 25262369, PMID 32588430, PMID 35224730

NIH funding

P01HL076611 (1), R01HL084155 (1), UL1TR000135 (1)